254 related articles for article (PubMed ID: 19387843)
1. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
[TBL] [Abstract][Full Text] [Related]
2. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
3. Correlation of dissolution and disintegration results for an immediate-release tablet.
Nickerson B; Kong A; Gerst P; Kao S
J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
[TBL] [Abstract][Full Text] [Related]
4. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
5. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
Uebbing L; Klumpp L; Webster GK; Löbenberg R
Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
[TBL] [Abstract][Full Text] [Related]
6. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
7. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
[TBL] [Abstract][Full Text] [Related]
8. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
Tarimci N; Celebi N
Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
[TBL] [Abstract][Full Text] [Related]
9. Fast disintegrating tablets containing Rhodiola rosea L. extract.
Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
Battu SK; Repka MA; Majumdar S; Madhusudan RY
Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
[TBL] [Abstract][Full Text] [Related]
11. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
Zaheer K; Langguth P
Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
[TBL] [Abstract][Full Text] [Related]
12. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
13. Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets.
Bafail R; Rawas-Qalaji M; Rawas-Qalaji M; Aodah A
Drug Dev Ind Pharm; 2019 Oct; 45(10):1617-1623. PubMed ID: 31353966
[No Abstract] [Full Text] [Related]
14. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
Zaheer K; Langguth P
Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Food Thickeners on the Disintegration, Dissolution, and Drug Activity of Rapid Oral-disintegrating Tablets].
Tomita T; Kohda Y; Kudo K
Yakugaku Zasshi; 2018; 138(3):353-356. PubMed ID: 29503428
[TBL] [Abstract][Full Text] [Related]
16. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
Fukami J; Yonemochi E; Yoshihashi Y; Terada K
Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
[TBL] [Abstract][Full Text] [Related]
18. Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations.
Maclean N; Walsh E; Soundaranathan M; Khadra I; Mann J; Williams H; Markl D
Int J Pharm; 2021 Apr; 599():120221. PubMed ID: 33540006
[TBL] [Abstract][Full Text] [Related]
19. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
